I agree that this site is using cookies. You can find further informations here.
X
Kawanishi, Masafumi
43  results:
Search for persons X
?
1

Population Pharmacokinetics of Ozoralizumab in Patients wit..:

Takeuchi, Tsutomu ; Chino, Yukihiro ; Mano, Yoko...
The Journal of Clinical Pharmacology.  64 (2023)  4 - p. 418-427 , 2023
Link: https://doi.org/10.1002/..
 
?
2

Effect of the extended dosing interval of anti-TNF-α NANOBO..:

Takeuchi, Tsutomu ; Nakanishi, Megumi ; Kawanishi, Masafumi..
Modern Rheumatology.  34 (2023)  4 - p. 678-685 , 2023
Link: https://doi.org/10.1093/..
 
?
3

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα..:

Takeuchi, Tsutomu ; Chino, Yukihiro ; Kawanishi, Masafumi...
Arthritis Research & Therapy.  25 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
4

Efficacy and safety of anti-TNF multivalent NANOBODY® compo..:

Tanaka, Yoshiya ; Kawanishi, Masafumi ; Nakanishi, Megumi..
Modern Rheumatology.  33 (2022)  5 - p. 875-882 , 2022
Link: https://doi.org/10.1093/..
 
?
5

Efficacy and safety of the anti-TNF multivalent NANOBODY® c..:

Tanaka, Yoshiya ; Kawanishi, Masafumi ; Nakanishi, Megumi..
Modern Rheumatology.  33 (2022)  5 - p. 883-890 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Phase II/III Results of a Trial of Anti–Tumor Necrosis Fact..:

Takeuchi, Tsutomu ; Kawanishi, Masafumi ; Nakanishi, Megumi..
Arthritis & Rheumatology.  74 (2022)  11 - p. 1776-1785 , 2022
Link: https://doi.org/10.1002/..
 
?
7

NT-702 (parogrelil hydrochloride, NM-702), a novel and pote..:

Hori, Miyuki ; Iwama, Takehisa ; Asakura, Yumiko...
European Journal of Pharmacology.  618 (2009)  1-3 - p. 63-69 , 2009
Link: https://doi.org/10.1016/..
 
?
8

NT-702 (parogrelil hydrochloride, NM-702), a novel and pote..:

Ishiwata, Norihisa ; Noguchi, Kazuo ; Kawanishi, Masafumi...
Life Sciences.  81 (2007)  12 - p. 970-978 , 2007
Link: https://doi.org/10.1016/..
 
?
9

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα..:

Takeuchi, Tsutomu ; Chino, Yukihiro ; Kawanishi, Masafumi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099673/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
10

Phase II/III Results of a Trial of Anti–Tumor Necrosis Fact..:

Takeuchi, Tsutomu ; Kawanishi, Masafumi ; Nakanishi, Megumi..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828347/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Efficacy and pharmacokinetics of ozoralizumab, an anti-TNFα..:

Tsutomu Takeuchi ; Yukihiro Chino ; Masafumi Kawanishi...
https://doi.org/10.1186/s13075-023-03036-4.  , 2023
Link: https://doi.org/10.1186/..
 
?
12

Myonectin protects against skeletal muscle dysfunction in m..:

Ozaki, Yuta ; Ohashi, Koji ; Otaka, Naoya...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
13

Indications for Percutaneous Drainage in Patients with Huan..:

Fukunaga, Shohei ; Naito, Yumi ; Hoshino, Yuki...
Internal Medicine.  62 (2023)  19 - p. 2871-2876 , 2023
Link: https://doi.org/10.2169/..
 
?
14

Utility of renal biopsy in differentiating idiopathic multi..:

Kawanishi, Miharu ; Kamei, Fumika ; Sonoda, Hirotaka...
CEN Case Reports.  12 (2022)  2 - p. 242-248 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Effectiveness of CKD Exacerbation Countermeasures in Izumo ..:

Ito, Takafumi ; Kamei, Fumika ; Sonoda, Hirotaka...
Journal of Personalized Medicine.  11 (2021)  11 - p. 1104 , 2021
Link: https://doi.org/10.3390/..
 
1-15